CORONA Remedies Limited (CORONA) Share Price
NSE · Healthcare · Drug Manufacturers - General · ISIN INE02ZQ01018
₹2,093.00+9.80 (+0.47%)
Key metrics
- Market Cap
- —
- P/E Ratio
- 63.98
- EPS
- 32.5
- Book Value
- 122.12
- P/B Ratio
- 17.14
- ROE
- 24.79%
- ROCE
- 28.11%
- Debt / Equity
- 0.22
- Net Margin
- 13.21%
- Revenue Growth
- 17.23%
- Profit Growth
- 23.88%
- Dividend Yield
- 0.48%
- 52W High
- ₹2,270.10
- 52W Low
- ₹1,336.60
- Market Cap Band
- —
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About CORONA Remedies Limited
CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products. It provides products in women's healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, nutraceuticals, gastroenterology, and other therapeutic areas. The company was incorporated in 2004 and is based in Ahmedabad, India.
- Headquarters
- Ahmedabad, India
- Employees
- 5,153
- Promoter Holding
- 81.68%
The full CORONA Remedies Limited analysis
Create a free account to open the complete CORONA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.